Business - CNBC
-
Millions more Americans could access obesity drugs after Trump's deals with Eli Lilly, Novo Nordisk
-
Airlines cancel more than 700 U.S. flights as FAA-ordered shutdown cuts begin
-
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
-
Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk
-
Target's sloppier stores are wearing on shoppers, and its turnaround could hinge on cleaning them up
-
FAA announces flight reductions at 40 airports. Here's where cuts are expected and what travelers need to know
-
Peloton posts bullish holiday forecast, betting that shoppers will spend big on new product lineup
-
McDonald's U.S. boss puts focus on 'value and affordability' as consumer spending splits
-
Startup Omada Health to start prescribing GLP-1s, other obesity medications as membership grows
-
Retailers' holiday hiring to hit lowest level since the Great Recession, says major industry trade group
-
Younger consumers are eating less Chipotle and Cava. They are buying more Coach bags
-
This fintech unicorn just launched an AI agent to handle billions of dollars in CRE lending
-
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
-
Peloton recalls 833,000 more bikes over seat post issue, two injuries reported
-
CarMax stock falls 24% as CEO steps down, used car retailer releases weak outlook
-
DraftKings takes over ESPN sports betting partnership from Penn Entertainment
-
Family offices make fewer deals but still flock to AI startup mega-rounds
-
NWSL creates star-studded advisory board to guide league's growth
-
E.l.f. Beauty stock plunges 29% on weak guidance, tariff impact
-
Lucid misses Wall Street expectations, narrows production guidance